🇺🇸 FDA
Pipeline program

Cannabidiol - fsCBD

23-0373

Phase 2 small_molecule active

Quick answer

Cannabidiol - fsCBD for Cannabis Use Disorder is a Phase 2 program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Cannabis Use Disorder
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials